H. Ishihara

发表

4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.

K. Miyazaki, M. Kakiki, N. Watanabe, 2000, Journal of medicinal chemistry.

4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.

K. Miyazaki, N. Watanabe, H. Adachi, 1998, Journal of medicinal chemistry.

4‐Benzylamino‐1‐chloro‐6‐Substituted Phthalazines: Synthesis and Inhibitory Activity Toward Phosphodiesterase 5.

K. Miyazaki, N. Watanabe, H. Adachi, 1998 .

A Small-Animal Pharmacokinetic/Pharmacodynamic PET Study of Central Serotonin 1A Receptor Occupancy by a Potential Therapeutic Agent for Overactive Bladder

Ming-Rong Zhang, T. Suhara, J. Maeda, 2013, PloS one.

In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.

M. Miyazaki, H. Okunishi, Y. Oka, 1993, Japanese journal of pharmacology.

Discovery and development of aryl-fused imidazole-based angiotensin II antagonists

T. Matsuoka, T. Musha, O. Hiroshima, 1994 .

Mushroom yield of cultivated shiitake (Lentinula edodes) and fungal communities in logs

Takuya Kobayashi, Hisatomo Taki, M. Akiba, 2020, Journal of Forest Research.

Pharmacology of E4101, a novel, selective and orally active DA-1 dopamine receptor agonist

T. Matsuoka, S. Suda, N. Mori, 1990 .